Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Oct;101(10):2351-2352.
doi: 10.1007/s00277-022-04898-5. Epub 2022 Jun 25.

Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis

Masaki Iino  1 , Tomoya Sato  2 , Ayato Nakadate  2 , Tomoya Onuki  2   3 , Nobuyuki Takayama  3
Affiliations
Observational Study

Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis

Masaki Iino et al. Ann Hematol. 2022 Oct.
No abstract available

PubMed Disclaimer

References

    1. Kitahara H, Maruyama D, Maeshima AM et al (2017) Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment. Ann Hematol 96(3):411–420 - DOI
    1. Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project. J Clin Oncol 26(25):4124–4130 - DOI
    1. Ogura M, Tsukasaki K, Nagai H et al (2012) Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T/natural killer-cell malignancies. Cancer Sci 103(7):1290–1295 - DOI
    1. Maruyama D, Tsukasaki K, Uchida T et al (2019) Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma. Ann Hematol 98(1):131–142 - DOI
    1. International non-Hodgkin’s lymphoma prognostic factors project (1993) A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 329(14):987–994 - DOI

LinkOut - more resources